Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Cancers|July 2, 2021
Automated Quantification of sTIL Density with H&E-Based Digital Image Analysis Has Prognostic Potential in Triple-Negative Breast CancersJeppe Thagaard, Elisabeth Specht Stovgaard, Line Grove Vognsen, et al.
American Heart Journal|November 12, 2022
Prognosis of acute coronary syndrome stratified by cancer type and status - a nationwide cohort studyNina Nouhravesh, Jarl E Strange, Jacob Tønnesen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 29, 2015
Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapyKaren-Lise Garm Spindler, Niels Pallisgaard, Ane Lindegaard Appelt, et al.
Cancers|September 14, 2024
Limited Evidence for the Benefits of Exercise in Older Adults with Hematological Malignancies: A Systematic Review and Meta-AnalysisMary Jarden, Sofie Tscherning Lindholm, Gudrun Kaldan, et al.
Cancer Chemotherapy and Pharmacology|August 6, 2015
Olaparib tablet formulation: effect of food on the pharmacokinetics after oral dosing in patients with advanced solid tumoursRuth Plummer, Helen Swaisland, Karin Leunen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 2, 2023
Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)Inna M Chen, Marco Donia, Christopher A Chamberlain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2024
Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 StudyAlice Markussen, Julia S Johansen, Finn O Larsen, et al.
British Journal of Cancer|November 24, 2020
A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumoursMark T J van Bussel, Ahmad Awada, Maja J A de Jonge, et al.
JACC. Cardiooncology|January 6, 2022
Risk for Myocardial Infarction Following 5-Fluorouracil Treatment in Patients With Gastrointestinal Cancer: A Nationwide Registry-Based StudyJan Walter Dhillon Shanmuganathan, Kristian Kragholm, Bhupendar Tayal, et al.
Clinical Therapeutics|October 18, 2016
Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-label StudiesLuc Dirix, Helen Swaisland, Henk M W Verheul, et al.
Pageof 9